Study the OnCS credential by organizing content around treatment phase rather than diagnosis. For every impairment you encounter in review, ask what intervention caused it, whether it is an acute effect, a persistent effect, or a late effect, and which rehab precaution or exercise-dosing decision follows. Work through paper scenarios that force a differential between look-alike presentations, and check yourself with a rubric that scores whether each decision names the treatment effect that justifies it. Administrative details such as eligibility and testing live on the ABPTS website at specialty.apta.org.
Why Treatment Phase, Not Diagnosis, Should Drive Your Plan of Care
The same cancer diagnosis produces different rehab problems before treatment, during active systemic therapy, and years into survivorship. Phase determines precautions, red flags, exercise dosing, and goals, so build your study structure around it.
Take one breast cancer patient across time. Two weeks after surgery, the dominant issues are wound status, axillary web syndrome, and shoulder range-of-motion limits set by surgical precautions. During active taxane-based chemotherapy, fatigue and chemotherapy-induced peripheral neuropathy dominate, and the risk profile shifts toward falls, anemia, and infection-related blood count changes. Five years out, lymphedema risk, aromatase-inhibitor arthralgia, and surveillance for cardiotoxicity may define the picture. One diagnosis, three different patients.
Turn this into your primary study artifact: for each major diagnosis in the published content areas, write three columns labeled pretreatment or early postoperative, active systemic treatment, and survivorship. Under each, list expected impairments, precautions, red flags, and intervention priorities. This structure converts memorization into retrieval practice when you make it the frame for every practice case you build: write each vignette so the patient is placed explicitly in one of these phases, and treat identifying the phase as your first decision before any intervention choice.
Metastasis Patterns and the Red Flags You Must Act On
Pathophysiology matters most in rehab as pattern recognition: which cancers seed which organs, and what findings constitute an oncologic emergency requiring immediate medical communication rather than routine rehab progression.
Anchor yourself to the classic patterns: breast, prostate, and lung commonly involve bone; lung and breast commonly involve brain. Learn the distinction between lytic lesions, which thin bone, and blastic lesions, which create dense but structurally abnormal bone. Then attach actions to findings: new thoracic back pain that is worse lying down, new saddle anesthesia or bowel and bladder change, unrelenting night pain unrelated to position, new headache with morning vomiting, or facial and neck swelling each warrants stopping routine rehab and escalating to the medical team promptly.
Build a one-page red flag grid with three columns: system involved, observable findings, and your immediate action. Populate it from a hematology-oncology or cancer rehabilitation reference, then test yourself by covering the action column. Your self-check is behavioral, not theoretical: given any finding on the grid, you can state the action without hesitation. If you pause to reason through whether something is emergent, that row is not yet learned, and it belongs in your next study cycle.
Comparing Surgery, Chemotherapy, Radiation, and Hormone or Targeted Therapy
Each modality produces a signature set of acute and late effects. Learn them side by side so a vignette cue, such as a rigid irradiated joint or distal numbness on infusion days, points you to the right cause.
Study the modalities as a comparison set, not as separate chapters. Surgical effects are structural and local; chemotherapy effects are systemic and often cycle-timed; radiation effects are field-localized but can progress over years as fibrosis; hormone and targeted therapies produce chronic low-grade effects such as arthralgia and bone density loss, while immunotherapy can trigger immune-related adverse events in nearly any organ. When you see a finding in a case, name the modality before naming the intervention, because the modality predicts the trajectory.
Then look for cross-modal compounding, which is where combined-treatment cases get difficult. A patient treated with chemotherapy plus radiation to the chest carries both a systemic cardiotoxicity exposure and a field-localized pulmonary or fibrosis risk, so endurance dosing must respect both. A neck dissection patient who also received radiation has surgical nerve deficits plus progressive soft-tissue tightening. Practice writing two-line justifications that cite both exposures, because single-cause reasoning is the predictable error in combined-modality practice cases.
| Modality | Typical acute effects | Representative late effects | Rehab priority |
|---|---|---|---|
| Surgery | Pain, restricted ROM, axillary web syndrome, lymph node disruption | Lymphedema, scar and soft-tissue restriction, nerve deficits after dissection | Early mobility and ROM within documented surgical precautions |
| Chemotherapy | Fatigue, nausea, mucositis, anemia, chemotherapy-induced peripheral neuropathy | Persistent neuropathy, cardiotoxicity exposure, cognitive complaints | Symptom-paced activity; monitor vitals and symptom timing relative to infusion cycles |
| Radiation | Skin reaction, fatigue, site-specific mucositis or esophagitis | Fibrosis, progressive ROM loss in irradiated joints, lymphatic damage in field | Maintain mobility of irradiated regions; protect irradiated skin |
| Hormone, targeted, immunotherapy | Arthralgia, immune-related adverse events in any organ | Bone density loss with aromatase inhibitors, chronic joint symptoms | Joint protection, bone health awareness, report new systemic symptoms to the team |
Distinguishing Deconditioning, Anemia, CIPN, and Cancer-Related Fatigue
These four presentations overlap in the words patients use, so assessment is a hypothesis test. Map each symptom to the infusion calendar, run targeted observations, and let the pattern select the intervention.
Worked scenario: a 62-year-old with colorectal cancer on an oxaliplatin-based regimen reports imbalance and leg heaviness and asks to restart a walking program. The predictable mistake is treating this as deconditioning and prescribing progressive endurance and gait training. The better decision is to differentiate first: chemotherapy-induced peripheral neuropathy suggests itself with distal numbness, loss of vibration and proprioception, and symptoms that fluctuate around infusion cycles; anemia suggests exertional dyspnea, dizziness, and elevated resting heart rate; cancer-related fatigue suggests exhaustion disproportionate to activity that rest does not reliably resolve. Observe Romberg and single-leg stance with eyes open and closed, distal sensation, and orthostatic vitals, then check symptom timing against the infusion calendar.
Why the differentiation matters: the interventions diverge sharply. Sensory-loss balance training leans on visual compensation, firm surfaces, and fall precautions, and pushing endurance work before stability is addressed invites a fall. Suspected anemia calls for reduced intensity and medical communication before progression. Build a practice battery you can apply to any vignette: symptom-to-cycle mapping, distal sensory testing, orthostatic vitals, a timed sit-to-stand, and a functional reach test. Document which hypothesis each observation supports or rules out, and notice when the data leave two hypotheses standing rather than forcing a premature single answer.
Dosing Exercise Around Bone Metastases and Active Treatment
Exercise prescription in oncology is conditional on lesion status, counts, and phase. Rehearse the decisions that change with those conditions, especially loading decisions near known metastases.
Worked scenario: a 58-year-old with prostate cancer and documented blastic lesions at T8 and in one femur is referred for strengthening. The predictable mistake is defaulting to a standard progression, including loaded squats and resisted hip flexion through large ranges. The better decision is to stop and ask what stability status and weight-bearing restrictions the medical team has documented, keep all movement within pain-free ranges, avoid loaded end-range flexion and rotation of the involved spinal segment, monitor for any new focal pain, and build strength through submaximal patterns consistent with the communicated restrictions. Decisions about specific loading thresholds near metastases belong to the medical team, not to rehab judgment alone.
Why it matters: a pathological fracture changes a patient's trajectory far more than a slower strength gain does, and the information that prevents it, lesion location and stability status, lives outside the rehab chart. Extend the same conditional thinking to the rest of dosing: during active systemic treatment, use flexible dosing such as short activity bouts that tolerate bad days, and track symptom timing relative to treatment days. In survivorship, progress toward standard exercise guidelines while watching late effects such as neuropathy persistence or cardiac history. Practice writing the dosing change and the named treatment effect that justifies it as one sentence.
Cancer-Related Cognitive Impairment and Distress: Assess Without Conflating Them
Cognitive complaints, fatigue, low mood, and medication or sleep effects present similarly. Differentiate them with structured comparison of self-report against brief objective observation, and treat distress screening as a brief referral decision.
Cancer-related cognitive impairment, often called chemo-fog in everyday language, centers on attention, processing speed, and working memory complaints that emerge around systemic therapy. Your assessment task is to separate it from contributors that present the same way: unrefreshing sleep, anemia, thyroid or medication changes, and mood. In a practice vignette, notice which contributor the details point toward, and rehearse stating what reversible factor you would ask the medical team to rule out before attributing the presentation to treatment-related cognition alone.
Distress assessment is a different skill with a different scope: a brief validated screen, a threshold decision, and a referral pathway. Distinguish normal adjustment reactions from clinically significant distress indicated by the screen, and resist role creep into psychotherapy. For study purposes, pair these two topics deliberately and write practice cases that combine them: a patient with word-finding trouble, poor sleep, and tearfulness requires you to name both the cognitive differential and the screening action, in that order, rather than collapsing everything into one label.
Late Effects, Special Populations, and Your Readiness Checklist
Late effects surface years after treatment ends and define several special populations. Build surveillance-oriented thinking for pediatric survivors, head and neck cancer, and cardiotoxic exposure, then rehearse full cases against a rubric.
Learn the signature late effects per population. Pediatric and adolescent survivors carry surveillance needs across cardiac, pulmonary, endocrine, cognitive, and second-malignancy domains, so rehab goals sit inside a lifelong monitoring context. Head and neck survivors combine trismus, neck and facial lymphedema, dysphagia, and shoulder dysfunction after neck dissection affecting the spinal accessory nerve, often with radiation fibrosis layered on. Survivors with anthracycline or chest-radiation exposure need their cardiac history treated as an active variable in endurance prescription, not as settled history.
Practical exercise with a self-check rubric: select one survivor case from a textbook or casebook and score yourself one to four points in five categories: named the treatments and current phase; listed at least three phase-appropriate precautions; identified two red flags with actions; justified the exercise dose with a named treatment effect; flagged the psychosocial or cognitive screen. A learning milestone is consistently reaching full marks in at least four of five categories across different cases; this is a study benchmark, not a prediction of any exam result. A realistic eight-week sequence: weeks one and two, build treatment-phase maps per diagnosis; weeks three and four, red flag grids and the assessment differentials; weeks five and six, dosing scenarios including bone metastasis cases; week seven, late effects checklists per population; week eight, mixed simulated cases scored with the rubric. Readiness checks: you can produce a three-phase map from memory in five minutes, state an action for every grid row without hesitation, and write a one-sentence dose justification citing the causal treatment effect.
References and further reading
Use these references to explore the concepts and check the latest information from the relevant organizations.